← Open Payments lookup

SUMMER MORGAN: Open Payments

NPI 1770031593 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$239 in 13 payments from 9 companies in 2025. Trend: 2023 $355 · 2024 $218 · 2025 $239

Food & beverage: $239
CompanyPaymentsAmount
ABBVIE INC.2$57
Sumitomo Pharma America, Inc.3$55
Astellas Pharma US Inc2$36
MILLICENT US INC1$21
Organogenesis Inc.1$18
Organon LLC1$17
Exeltis, USA Inc.1$16
Bayer Healthcare Pharmaceuticals Inc.1$15
MAYNE PHARMA COMMERCIAL LLC1$3

Products named: Veozah, IMBRUVICA, GEMTESA, EMRELIS, MYFEMBREE, FEMLYV, PURAPLY WOUND MATRIX, NEXPLANON.

Industry payments across MO — which companies pay providers there.